Colorectal Cancer News and Research

Latest Colorectal Cancer News and Research

AVEO announces data from planned interim analysis of Phase 2 BATON study in CRC patients

AVEO Oncology today announced that data from a planned interim analysis of the Phase 2 BATON (Biomarker Assessment of Tivozanib in ONcology) study in patients with colorectal cancer (CRC) indicate that the study is unlikely to meet the primary endpoint in the intent-to-treat patient population.

13 Dec 2013

Circulating nucleosomes and colorectal cancer diagnostics: an interview with Dr. Stefan Holdenrieder, University Hospital Bonn

For my MD thesis I modified and evaluated an immunological assay that detected the cell death products “nucleosomes” as a new blood-based cancer biomarker. As cell death processes are enhanced or suppressed during different stages of tumor development, it was assumed that they may enable stage-dependent detection of cancer disease.

12 Dec 2013

Queen's University to lead €6 million European study to find new treatments for bowel cancer

Queen's University has announced it is to lead a -6 million European study to find new treatments for bowel cancer.

12 Dec 2013

Report: Screen all endometrial cancer patients for Lynch syndrome

A recent article by Norris Cotton Cancer Center researchers published in the January 2014 issue of the journal Clinical Chemistry reviews the scientific evidence that warrants screening all endometrial cancers for Lynch syndrome. Next to colorectal cancer, endometrial cancer is the most common form of cancer in women with Lynch syndrome.

12 Dec 2013

Queen's University heads key European study to find new treatments for bowel cancer

Queen's University has announced it is to lead a €6 million European study to find new treatments for bowel cancer.

11 Dec 2013

Navidea receives Fast Track designation for Lymphoseek injection

Navidea Biopharmaceuticals, Inc. (NYSE MKT:NAVB), a biopharmaceutical company focused on precision diagnostic radiopharmaceuticals, announced today that the US Food and Drug Administration (FDA) has granted Fast Track designation to Lymphoseek® (technetium 99m tilmanocept) Injection for sentinel lymph node detection in patients with head and neck cancer.

11 Dec 2013

Decreased bacterial diversity in gut linked with CRC risk

Decreased diversity in the microbial community found in the human gut is associated with colorectal cancer, according to a new study published December 6 in the Journal of the National Cancer Institute.

9 Dec 2013

NYU Langone Medical Center researchers find link between gut bacteria and colorectal cancer

In one of the largest epidemiological studies of human gut bacteria and colorectal cancer ever conducted, a team of researchers at NYU Langone Medical Center has found a clear association between gut bacteria and colorectal cancer. The study, published today in the Journal of the National Cancer Institute, discovered that colorectal cancer patients had fewer beneficial bacteria and more harmful bacteria than people without the disease.

6 Dec 2013

Silverlink, UnitedHealthcare recognized for increasing colorectal cancer screenings among minorities

Silverlink Communications, Inc., and UnitedHealthcare's program to increase colorectal cancer screenings among minority populations earned the companies a 2013 Outstanding Leadership in Population Health Award from the Care Continuum Alliance at the recent CCA Forum 2013.

6 Dec 2013

Low vitamin D levels: Not a cause but a consequence of ill health

A comprehensive review of the evidence suggests that low vitamin D levels are not a cause but a consequence of ill health, casting strong doubt on the value of vitamin D supplements to protect against acute and chronic disorders such as cancer, cardiovascular disease, diabetes, Parkinson’s disease, and even death.

6 Dec 2013

Biocartis, VIB partner to develop novel MSI biomarkers for colorectal cancer

Today Biocartis and VIB announced their exclusive license agreement on a novel panel of microsatellite instability biomarkers for several cancers, in particular colorectal cancer.

From Biocartis 6 Dec 2013

Obama seeks to connect with young adults, encourage them to sign up for coverage

The 18-35 year-old demographic is seen as key to achieving stability in the new online insurance marketplaces. But reaching this group is no easy task -- their interest and support for the health law appears to be waning.

6 Dec 2013

Study shows it is not too late to stop smoking after cancer diagnosis

Men who continued to smoke after a cancer diagnosis had an increased risk of death compared with those who quit smoking after diagnosis, according to a study published in Cancer Epidemiology, Biomarkers & Prevention, a journal of the American Association for Cancer Research.

6 Dec 2013

Presence Health uses automated IVR calls to increase colorectal cancer screening rates

Presence Health, the largest Catholic health system based in Illinois, significantly increased screening rates for colorectal cancer by utilizing automated, interactive voice response calls, according to research being presented on Dec. 10 at the Institute for Healthcare Improvement's 25th Annual National Forum on Quality Improvement in Health Care.

5 Dec 2013

First Edition: December 5, 2013

Today's headlines include reports about how President Barack Obama is trying to connect with young adults and urge them to sign up for health coverage.

5 Dec 2013

Researchers find correlation between biomarker and patient’s ability to respond to Imprime PGG

Biothera researchers have broadened their understanding of a biomarker that may enable doctors to predict which cancer patients will best respond to Imprime PGG®, the company's immunotherapy in Phase 3 drug development for colorectal cancer.

5 Dec 2013

Lung cancer is costliest cancer in European Union

The total cost of cancer care across the European Union was an estimated € 126 billion in 2009, with lung cancer having the highest cost, at 15% of the total.

4 Dec 2013

SMART's G-EYE balloon technology to be integrated on PENTAX Medical's full HD+ colonoscopes

SMART Medical Systems Ltd., a developer and manufacturer of innovative endoscopy products, announced a strategic alliance with PENTAX Medical, an industry leader in endoscopic imaging. Under the alliance, SMART's novel G-EYE™ balloon technology will be integrated on PENTAX Medical's full HD+ colonoscopes, and will be distributed by PENTAX Medical in Europe, the Middle East and Africa.

4 Dec 2013

VolitionRx's two-assay test can detect 85% of colorectal cancer, more than 50% of precancerous polyps

VolitionRx Limited, a life sciences company focused on developing blood-based diagnostic tests for different types of cancer, today releases new data showing that when combining two of its proprietary NuQ assays into one test, they can achieve 85% detection rates at 85% specificity for colorectal cancer. The data also shows that Volition’s two-assay test can detect more than 50% of precancerous polyps. These new findings come from its ongoing prospective study with CHU Dinant Godinne | UCL Namur Hospital in Belgium.

4 Dec 2013

Findings could have important implications for personalized treatment of colon cancer

A common observation in oncology is the phenomenon that a patient with a tumor receives a drug and responds very well, but after a few months the cancer comes back and is now resistant to previously administered chemotherapy. What happened? Many mechanisms contribute to explain this effect called "acquired resistance", but today the group Manel Esteller, Director of Epigenetics and Cancer Biology at the Bellvitge Biomedical Research Institute, ICREA researcher and Professor of Genetics at the University of Barcelona, describes in the official Journal of the National Cancer Research Center in the United States, The Journal of The National Cancer Institute, the existence of epigenetic differences that explain the lack of response of the tumor recurs.

4 Dec 2013

Colorectal Cancer News and Research

Latest Colorectal Cancer News and Research

AVEO announces data from planned interim analysis of Phase 2 BATON study in CRC patients

Circulating nucleosomes and colorectal cancer diagnostics: an interview with Dr. Stefan Holdenrieder, University Hospital Bonn

Queen's University to lead €6 million European study to find new treatments for bowel cancer

Report: Screen all endometrial cancer patients for Lynch syndrome

Queen's University heads key European study to find new treatments for bowel cancer

Navidea receives Fast Track designation for Lymphoseek injection

Decreased bacterial diversity in gut linked with CRC risk

NYU Langone Medical Center researchers find link between gut bacteria and colorectal cancer

Silverlink, UnitedHealthcare recognized for increasing colorectal cancer screenings among minorities

Low vitamin D levels: Not a cause but a consequence of ill health

Biocartis, VIB partner to develop novel MSI biomarkers for colorectal cancer

Obama seeks to connect with young adults, encourage them to sign up for coverage

Study shows it is not too late to stop smoking after cancer diagnosis

Presence Health uses automated IVR calls to increase colorectal cancer screening rates

First Edition: December 5, 2013

Researchers find correlation between biomarker and patient’s ability to respond to Imprime PGG

Lung cancer is costliest cancer in European Union

SMART's G-EYE balloon technology to be integrated on PENTAX Medical's full HD+ colonoscopes

VolitionRx's two-assay test can detect 85% of colorectal cancer, more than 50% of precancerous polyps

Findings could have important implications for personalized treatment of colon cancer

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Freezing Point Osmometry in Life Science Applications

Precision in every drop: Inside Hamilton’s syringe technology

Colorectal Cancer News and Research

Latest Colorectal Cancer News and Research

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Freezing Point Osmometry in Life Science Applications

Precision in every drop: Inside Hamilton’s syringe technology

Newsletters you may be interested in